Request a Proposal  

Welcome to Pharm-Olam Insights

Check out our latest white paper! We partnered with Informa Pharma Intelligence to bring you the latest information on COVID-19 and its effect on the clinical landscape.

8 Strategies for Navigating Clinical Studies During COVID-19

COVID-19 has presented a variety of challenges. The way people live their lives and conduct their work has been disrupted....

(3 minute read)

Tags: Pharm-Olam Insights, COVID-19

Understanding the Connection Between COVID-19 and VAP

Ventilator-Associated Pneumonia (VAP) is a common complication of mechanical ventilation. Overall, the percentage of VAP or...

(3 minute read)

Tags: COVID-19

The COVID 19 Map per ClinicalTrial Gov

The COVID Pandemic is continuing to evolve. Governments and companies around the world are striving to develop vaccines and...

(8 minute read)

Tags: Infectious Disease & Vaccines, COVID-19

Pharm-Olam Releases Updated Paper on the Impact of COVID on Clinical Research

Earlier this year, Pharm-Olam partnered with Informa’s Pharma Intelligence to draft a white paper that discusses the...

(1 minute read)

Tags: Infectious Disease & Vaccines, COVID-19, Global Coverage

6 Study Adaptations to Keep Studies Moving Despite COVID-19 Pandemic

The COVID-19 Pandemic continues to evolve and fluctuate across the globe – but not evenly or predictablySome countries have...

(22 minute read)

Tags: Pharm-Olam Insights, Infectious Disease & Vaccines, Investigator Insights,

Ethically Consenting Patients in Ventilator-Associated Studies

Pharm-Olam is experienced in dealing with ventilator-associated studies and consenting patients in an Intensive Care Unit...

(7 minute read)

Tags: Infectious Disease & Vaccines, COVID-19

Join other Clinical Development experts to receive the latest industry news, trends and insights.

Subscribe to our blog and we'll give you our GDPR Controller & Processor Checklist.